Tuning Hsp104 specificity to selectively detoxify alpha-synuclein
K. L. Mack, H. Kim, M. E. Jackrel, J. Lin, J. E. DeNizio, X. Yan, E. Chuang, A. Tariq, R. R. Cupo, L. M. Castellano, K. A. Caldwell, G. A. Caldwell, J. Shorter
The paper engineers Hsp104 variants with substrate specificity to selectively reduce alpha-synuclein toxicity in a Parkinson's disease model.
bioRxiv · Apr 15, 2020Bioengineering